Target Name: G protein-Coupled Inwardly-Rectifying Potassium Channel (GIRK)
NCBI ID: P28116
Review Report on G protein-Coupled Inwardly-Rectifying Potassium Channel (GIRK) Target / Biomarker Content of Review Report on G protein-Coupled Inwardly-Rectifying Potassium Channel (GIRK) Target / Biomarker
G protein-Coupled Inwardly-Rectifying Potassium Channel (GIRK)
Other Name(s): GIRK | GIRKs

GIRKs: Unraveling The Voltage-Dependent Ion Channels

G protein-coupled inwardly rectifying potassium channels (GIRKs) are a family of voltage-dependent ion channels that play a crucial role in various physiological processes, including muscle contractions, neurotransmitter release, and intracellular signaling. GIRKs are classified into three subtypes based on their ion selectivity, including GIRK1, GIRK2, and GIRK3. GIRK1 is the most abundant G protein-coupled channel and is responsible for the majority of the action potential generation in neurons. GIRK2 is known for its role in neurotransmitter release and has been targeted for therapeutic intervention in various neurological and psychiatric disorders. GIRK3 is a relatively little-studied channel that is involved in the regulation of pain perception and neuropeptide release.

GIRKs are characterized by their voltage-dependent ionation, which allows them to be sensitive to a wide range of membrane potentials. During depolarization, positively charged amino acids on the intracellular side of the channel interact with negatively charged amino acids on the extrinsic side, leading to the formation of a more positive charge on the intracellular side and a more negative charge on the extrinsic side. This creates a potential gradient across the membrane, which can be used to generate action potentials.

GIRKs are also characterized by their slow inactivation rate, which allows them to remain open for a long period of time, even during rest. This is important for maintaining the reliable function of the nervous system, as rapid inactivation of GIRKs can lead to rapid changes in the membrane potential, which can cause instability and disrupt the normal function of the nervous system.

GIRKs are involved in a wide range of physiological processes, including muscle contractions, neurotransmitter release, and intracellular signaling. They play a crucial role in the regulation of muscle movement and the transmission of neural signals. They are also involved in the regulation of neurotransmitter release, which is critical for the regulation of mood, pain perception, and other neurological and psychiatric disorders.

GIRKs are also involved in the regulation of intracellular signaling, which is critical for the regulation of cell growth, differentiation, and survival. They are involved in the regulation of cell proliferation, cell death, and the regulation of cell-cell interactions.

GIRKs are also involved in the regulation of pain perception and neuropeptide release. GIRKs have been shown to play a role in the regulation of pain perception and the release of neuropeptides, which are important for the regulation of mood, pain perception, and other neurological and psychiatric disorders.

GIRKs are also involved in the regulation of muscle tone and muscle contractions. They are involved in the regulation of muscle tone, which is critical for maintaining posture and movement. They are also involved in the regulation of muscle contractions, which is critical for muscle growth and development.

GIRKs are also involved in the regulation of neurotransmitter release and intracellular signaling. They are involved in the regulation of neurotransmitter release, which is critical for the regulation of mood, pain perception, and other neurological and psychiatric disorders. They are also involved in the regulation of intracellular signaling, which is critical for the regulation of cell growth, differentiation, and survival.

GIRKs are potential drug targets for a variety of neurological and psychiatric disorders. They are involved in the regulation of pain perception and neurotransmitter release, which makes them important targets for the treatment of pain disorders, neurotransmitter imbalances, and psychiatric disorders. They are also involved in the regulation of muscle tone and muscle contractions, which makes them important targets for the treatment of muscle disorders, such as myopathies and myopathic pain disorders.

In conclusion, G protein-coupled inwardly rectifying potassium channels (GIRKs) are a family of voltage-dependent ion channels that play a crucial role in various physiological processes

Protein Name: G Protein-Coupled Inwardly-Rectifying Potassium Channel (GIRK) (nonspecified Subtype)

The "G protein-Coupled Inwardly-Rectifying Potassium Channel (GIRK) Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about G protein-Coupled Inwardly-Rectifying Potassium Channel (GIRK) comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

G Protein-Coupled Receptor Kinases (GRKs) | G0S2 | G2E3 | G2E3-AS1 | G3BP1 | G3BP2 | G6PC1 | G6PC2 | G6PC3 | G6PD | GA-binding protein | GAA | GAB1 | GAB2 | GAB3 | GAB4 | GABA(A) receptor | GABARAP | GABARAPL1 | GABARAPL2 | GABARAPL3 | GABBR1 | GABBR2 | GABPA | GABPAP | GABPB1 | GABPB1-AS1 | GABPB1-IT1 | GABPB2 | GABRA1 | GABRA2 | GABRA3 | GABRA4 | GABRA5 | GABRA6 | GABRB1 | GABRB2 | GABRB3 | GABRD | GABRE | GABRG1 | GABRG2 | GABRG3 | GABRG3-AS1 | GABRP | GABRQ | GABRR1 | GABRR2 | GABRR3 | GACAT1 | GACAT2 | GACAT3 | GAD1 | GAD2 | GADD45A | GADD45B | GADD45G | GADD45GIP1 | GADL1 | GAGE1 | GAGE10 | GAGE12B | GAGE12C | GAGE12D | GAGE12F | GAGE12G | GAGE12H | GAGE12J | GAGE2A | GAGE2B | GAGE2C | GAGE2D | GAGE4 | GAGE5 | GAGE6 | GAGE7 | GAGE8 | GAK | GAL | GAL3ST1 | GAL3ST2 | GAL3ST3 | GAL3ST4 | Galanin receptor | GALC | GALE | GALK1 | GALK2 | GALM | GALNS | GALNT1 | GALNT10 | GALNT11 | GALNT12 | GALNT13 | GALNT13-AS1 | GALNT14 | GALNT15 | GALNT16 | GALNT17